We are live on ! Find out more
ACAD icon

Acadia Pharmaceuticals
ACAD

333 hedge funds and large institutions have $3.58B invested in Acadia Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 126 increasing their positions, 106 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 32

31% more call options, than puts

Call options by funds: $34.2M | Put options by funds: $26.1M

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

19% more repeat investments, than reductions

Existing positions increased: 126 | Existing positions reduced: 106

7% more funds holding

Funds holding: 310 → 333 (+23)

2% less capital invested

Capital invested by funds: $3.66B → $3.58B (-$84.3M)

2.07% less ownership

Funds ownership: 101.47% → 99.39% (-2.1%)

Holders
333
Holders Change
+23
Holders Change %
+7.42%
% of All Funds
4.37%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
58
Increased
126
Reduced
106
Closed
32
Calls
$34.2M
Puts
$26.1M
Net Calls
+$8.1M
Net Calls Change
-$3.96M

Top Buyers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
+$56.3M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$44.5M
3
Millennium Management
Millennium Management
New York
+$33.4M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$31M
5
State Street
State Street
Massachusetts
+$25.5M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$69.1M
2
Citadel Advisors
Citadel Advisors
Florida
-$63.6M
3
RI
RTW Investments
New York
-$43.8M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$39.9M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$39.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
FC
326
Financial Consulate
Maryland
$214 +$236 +10 New
SIC
327
SJS Investment Consulting
Ohio
$193 – – –
HIA
328
HFM Investment Advisors
New Jersey
$192 +$47 +2 +29%
AWM
329
Abound Wealth Management
Tennessee
$150 – – –
RWM
330
Rialto Wealth Management
New York
$150 +$118 +5 +250%
BMC
331
Bear Mountain Capital
Washington
$149 +$166 +7 New
BHWM
332
Bay Harbor Wealth Management
Maryland
$85 +$95 +4 New
Norges Bank
333
Norges Bank
Norway
– -$31.7M -1,468,647 Closed
SSA
334
Schonfeld Strategic Advisors
New York
– -$4.29M -199,024 Closed
JGC
335
J. Goldman & Co
New York
– -$3.89M -164,278 Closed
RAM
336
Readystate Asset Management
Illinois
– -$1.98M -91,999 Closed
Walleye Capital
337
Walleye Capital
New York
– -$2.08M -87,788 Closed
NRD
338
Nebula Research & Development
New York
– -$1.16M -53,571 Closed
UOC
339
UBS O'Connor
Illinois
– -$928K -43,000 Closed
PCM
340
Prelude Capital Management
New York
– -$593K -27,511 Closed
WG
341
Winton Group
United Kingdom
– -$544K -25,200 Closed
NWMG
342
National Wealth Management Group
Ohio
– -$469K -21,733 Closed
BFM
343
Boothbay Fund Management
New York
– -$473K -20,000 Closed
Simplex Trading
344
Simplex Trading
Illinois
– -$441K -18,631 Closed
FC
345
FORA Capital
Florida
– -$297K -13,746 Closed
SGI
346
Summit Global Investments
Utah
– -$232K -10,751 Closed
Walleye Trading
347
Walleye Trading
New York
– -$251K -10,624 Closed
NIM
348
NEOS Investment Management
Connecticut
– -$229K -10,596 Closed
TE
349
Tema ETFs
New York
– -$229K -10,596 Closed
DS
350
DRW Securities
Illinois
– -$222K -10,047 Closed
11 12 13
14
15

ACAD Hedge Fund Activity: Q3 2025 in Review

333 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Acadia Pharmaceuticals (ACAD) for Q3 2025, worth a combined $3.58B — down 2.3% from $3.66B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new ACAD positions and 32 closed out — a net gain of 26 holders — while 126 added to existing stakes and 106 trimmed.

The largest buyer was Braidwell, opening a new position worth an estimated $56.3M. The largest seller was Morgan Stanley, cutting an estimated $69.1M.

  • 333 institutional investors held Acadia Pharmaceuticals (ACAD) as of Q3 2025, up from 310 in Q2 2025.
  • Funds reported $3.58B of Acadia Pharmaceuticals stock for Q3 2025, down 2.3% quarter-over-quarter.
  • 58 funds opened new Acadia Pharmaceuticals positions in Q3 2025 and 32 closed out, a net change of +26 holders.
  • The largest Acadia Pharmaceuticals buyer in Q3 2025 was Braidwell, an estimated $56.3M added.
  • The largest Acadia Pharmaceuticals seller in Q3 2025 was Morgan Stanley, an estimated $69.1M sold.

Based on aggregated 13F filings for Q3 2025.